Reuters logo
BRIEF-Aclaris Therapeutics posts Q2 loss per share $‍0.56​
2017年8月8日 / 上午11点11分 / 3 个月前

BRIEF-Aclaris Therapeutics posts Q2 loss per share $‍0.56​

Aug 8 (Reuters) - Aclaris Therapeutics Inc

* Aclaris Therapeutics reports second quarter 2017 financial results

* Qtrly loss per share $‍0.56​

* ‍reiterates 2017 financial guidance for net cash burn, total operating expenses, research and development expenses​

* Aclaris Therapeutics - ‍sees its cash, cash equivalents, marketable securities as of June 30 sufficient to fund operations through at least end of 2018​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below